Practical strategies for navigating the capricious regulatory landscape and maximising the value of IP within Life Science
Intellectual Property is the life blood of any Life Science organisations, and the effective management, protection, and enforcement of IP’s is essential to achieve success in such a competitive market. Life Science IP is the only IP event designed for in-house IPR professionals with a focus on the key issues of the year, including the Doctrine of Equivalents, Second-Medical use claims and SPCs. Furthermore, the event will also provide attendees with commercial strategies for maximising the value of their existing IP portfolio and will simultaneously explore the viability reduced-costs methods of IP protection.
Early Confirmed Speakers Include
UK House of Lords
Director, Intellectual Property Policy
Dr. Matthias Zigann
Regional Court Munich I
Chairman of the Rules and Procedure Committee
Dr. Judy Jarecki-Black
Head, Patent Prosecution and Patent Litigation, Animal Health
Boehringer Ingelheim Animal Health
Jane Lambert QC
4-5 Gray's Inn Square
Professor Mark Engelman QC
Head of Intellectual Property, Barrister
Dr Sven Bostyn Lic.Jur., LLM, PhD
Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law
Dr Guido Pontremoli
Corporate IP Patent Director
Chief IP Counsel
New England Biolabs
CTO & IP Director
Discovery Chemistry and Intellectual Property Manager
Harbour Litigation Fund
University of Liverpool
Product Manager Orbit
Key Account Executive
Benefits of attending
Key Highlights to be addressed:
Receive updates and insights directly from the lawmakers, including QC Barrister Mark Engelman.
Learn more about the efficacy of patenting anti-bodies, biosimilars and bio-equivalents and how local experts are managing this at a regional level
Receive updates on the implications of recently concluded case law, including the Actavis 'Skinny Labelling' case. Hear how expert law firms and life sciences businesses will be adapting their IP strategy accordingly.
Work with industry experts, specialist law firms, licensing businesses and in-house counsels to generate effective IP portfolio management, commercialisation and monetisation strategies.
Discuss the viability of alternative forms of IP protection, including trade-secrets, confidential information, trademarks and copyright.
What our past attendees had to say about our events
“All the speakers at the conference were very high level and spoke on issues we are all battling with”
“It was really good for me to keep up to date in the latest development within IP which I cannot follow on a daily bases due to my various role in my company”
“This event has been valuable for the exchange of views, practical advices”
“IQPC’s group sessions are very useful and allowed more focused discussions. Furthermore, the scenarios allowed conversations to arise that wouldn’t have happened if we were just passively listening to talks”